Trial Profile
The NEURAPRO-Q (North America, EURope, Australia PROdrome) Study: A multicentre randomised controlled trial (RCT) to evaluate the effect of Quetiapine and Cognitive-Behavioural Case Management on the incidence of first episode psychosis in Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Psychotic disorders; Schizophrenia
- Focus Therapeutic Use
- Acronyms NEURAPRO-Q
- 06 Dec 2011 Status changed from not yet recruiting to discontinued as reported by Australian New Zealand Clinical Trials Registry.
- 18 Jul 2011 New trial record